Amylyx Pharmaceuticals (AMLX) Prepaid Assets (2021 - 2026)

Amylyx Pharmaceuticals' Prepaid Assets history runs 6 years deep, the most recent figure standing at $5.3 million for Q1 2026.

• On a quarterly basis, Prepaid Assets fell 55.37% year-over-year to $5.3 million in Q1 2026; TTM through Mar 2026 was $5.3 million, a 55.37% decrease from a year earlier, with the FY2025 full-year figure at $6.7 million, down 46.4% from the prior year.
• Prepaid Assets eased to $5.3 million in Q1 2026 per AMLX's latest filing, from $6.7 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $17.3 million in Q3 2023 and bottomed at $5.3 million in Q1 2026.
• The 5-year median for Prepaid Assets is $10.3 million (2022), against an average of $10.9 million.
• Across the five-year window, Prepaid Assets surged 107.99% in 2023 and tumbled 55.37% in 2026, its largest moves.
• Year by year, Prepaid Assets stood at $10.1 million in 2022, then soared by 47.64% to $14.9 million in 2023, then declined by 16.39% to $12.5 million in 2024, then sank by 46.4% to $6.7 million in 2025, then declined by 21.46% to $5.3 million in 2026.
• Per Business Quant, the three latest AMLX Prepaid Assets figures stand at $5.3 million (Q1 2026), $6.7 million (Q4 2025), and $9.3 million (Q3 2025).